Metro Atlanta is powered by manufacturing, technology, talent, and global connectivity.
From pharmaceutical manufacturing and health technology to cutting-edge research, metro Atlanta is assembling the ingredients of a globally competitive life sciences ecosystem. Rather than positioning itself as a lower-cost alternative to established coastal markets, metro Atlanta is building its own model for growth. Thanks to its strong infrastructure and collaborative innovation network, metro Atlanta is increasingly attracting companies looking to scale.
“We don’t want to be Boston. We’re Atlanta,” says Gregg Simon, Senior Vice President of Business Recruitment at the Metro Atlanta Chamber. “We are our own homegrown ecosystem for life sciences, and we have strengths that those other areas don’t have.”
Three sectors driving metro Atlanta’s life sciences growth
The region’s life sciences landscape is anchored by three fast-growing sectors: biopharmaceuticals, health IT, and medical devices.
In biopharmaceuticals, Takeda Pharmaceuticals produces medicines for patients worldwide from its Newton County facility. The medical device industry is also expanding, with Boston Scientific operating an endoscopy manufacturing facility in Johns Creek and animal health company Zoetis growing its presence in Douglas County. Health technology is another area of momentum, highlighted by Glide Tech’s decision to locate its headquarters in Cobb County, bringing 500 jobs focused on diabetes care technology.
Together, these investments reflect the breadth of metro Atlanta’s life sciences ecosystem, from advanced manufacturing to software-driven healthcare innovation.
A World-Class Talent Pipeline and Collaborative Infrastructure
A thriving life sciences sector depends on both highly skilled talent and cutting-edge research. Metro Atlanta offers access to both through a concentration of leading universities, medical institutions, and federal research assets.
Institutions including Emory University, the Georgia Institute of Technology, and Morehouse School of Medicine help supply the region with scientific, engineering, and healthcare talent. The presence of the Centers for Disease Control and Prevention further strengthens the research infrastructure and attracts experts from around the world.
This concentration of institutions has fostered a collaborative environment that is uncommon among major metropolitan areas. One example is the joint bioengineering program between Emory University and the Georgia Institute of Technology, which combines medical research expertise with advanced engineering capabilities.
That collaboration extends into innovation districts such as Science Square and Technology Enterprise Park, helping researchers translate discoveries into commercial ventures and accelerating the growth of emerging life sciences companies.
The Cold Chain and Corporate Relocation Advantage
Talent and research help generate innovation, but bringing new technologies to the market requires another critical capability: efficient distribution and business operations. That is where metro Atlanta’s logistics strengths become a significant competitive advantage.
Many medicines and biologics require strict temperature control throughout the shipping process. This specialized distribution network, known as “cold chain logistics,” is critical to ensuring product safety and effectiveness. Supported by major transportation assets and global supply-chain connectivity, Atlanta offers companies a strong foundation for managing these complex distribution needs.
The region also offers an attractive alternative to higher-cost coastal markets.
“Those other geographies are very expensive areas, and businesses there are having trouble recruiting talent because it’s just hard to live there,” Gregg explains.
Atlanta’s diverse workforce, business-friendly environment, and comparatively affordable cost of living continue to attract companies seeking to expand operations while maintaining access to skilled talent. As a result, some life sciences firms are increasingly evaluating the region for corporate functions such as finance, human resources, legal operations, and shared services.
Looking Ahead: AI and Personalized Medicine
The same assets driving growth today, including research institutions, technology talent, and advanced logistics capabilities, are also positioning metro Atlanta for the next wave of life sciences innovation. Institutions such as the Georgia Institute of Technology are expanding artificial intelligence education and research across disciplines. This talent pool could prove especially attractive to companies focused on automation, advanced analytics, and AI-enabled drug development.
At the same time, personalized medicine is creating new demands. Treatments tailored to an individual’s genetics, environment, and lifestyle often require more distributed and responsive manufacturing capabilities. The region is well positioned to support these evolving production and delivery models.
Metro Atlanta’s rise as a life sciences hub is not the result of following a blueprint established elsewhere. Instead, the region has developed its own rhythm built on collaboration, research excellence, advanced manufacturing, technology innovation, and global logistics. Backed by continued investment and a growing talent base, metro Atlanta is emerging as one of the nation’s most dynamic life sciences markets.
